Published on 6/29/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.
New Issue: Goldman Sachs prices $20 million notes exchangeable for Medtronic at 1%, up 14.25%
New York, June 29 - The Goldman Sachs Group, Inc. priced $20 million 1% notes exchangeable for the common stock of Medtronic, Inc. with a 14.25% initial exchange premium, according to a 424B3 filing with the Securities and Exchange Commission.
Medtronic is a Minneapolis-based medical technology company.
Issuer: | The Goldman Sachs Group, Inc.
|
Issue: | Exchangeable medium-term series B notes
|
Underlying stock: | Medtronic, Inc.
|
Amount: | $20 million
|
Maturity: | June 29, 2012
|
Coupon: | 1%
|
Price: | Par
|
Exchange premium: | 14.25%
|
Exchange price: | $59.313 (at any time)
|
Exchange ratio: | 16.8597 payable in cash or stock at maturity
|
Call: | June 29, 2008 onwards at par, automatic exchange if more valuable
|
Underwriter: | Goldman, Sachs & Co.
|
Pricing date: | June 22
|
Settlement: | June 29
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.